𝔖 Bobbio Scriptorium
✦   LIBER   ✦

METHODOLOGICAL APPROACHES IN PHARMACOEPIDEMIOLOGY – APPLICATION TO SPONTANEOUS REPORTING.

✍ Scribed by S. C. LEWIS

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
81 KB
Volume
15
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis

This book is a discussion of the mathematical and statistical aspects of pharmacovigilance as applicable to spontaneous reporting of adverse drug reactions. It starts very simply with a discussion of

📜 SIMILAR VOLUMES

Diverse approaches to “tasks” in informa
Diverse approaches to “tasks” in information science: Conceptual and methodological insights
✍ Eric Meyers; Theresa Anderson; Katriina Byström; Luanne Freund; Elaine Toms 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 60 KB

## Abstract The “task” is an important concept in Information Science, both as a theoretical and methodological tool. While many studies of information retrieval and information seeking and use take individual characteristics or system features as the starting point for their research, a growing bo

ChemInform Abstract: New Approaches to F
ChemInform Abstract: New Approaches to Fluorinated Ligands and Their Application in Catalysis.
✍ Weiping Chen; Lijin Xu; Yulai Hu; Anna M. Banet Osuna; Jianliang Xiao 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Biostatistical considerations in pharmac
Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studies
✍ Robert T. O'Neill 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

This paper deals with a conceptual discussion of a variety of statistical concepts, methods and strategies that are relevant to the quantitative assessment of risk derived from safety data collected during the pre-and post-marketing phase of a new drug's life cycle. A call is made for the use of mor